Therapeutic Monitoring Of Vancomycin For Serious MRSA Infections - Guideline Learning Activities - Guideline Central
The Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections guideline, developed by the American Society of Health-System Pharmacists, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, and Surgical Infection Society, provides evidence-based recommendations for vancomycin dosing and serum concentration monitoring in serious MRSA infections, including bacteremia, sepsis, infective endocarditis, pneumonia, osteomyelitis, and meningitis.
10
Questions
12
Minutes Est.
200
Possible Points
Unrated
Difficulty
Objectives
  • Understanding therapeutic monitoring of vancomycin for serious MRSA infections
  • Learning the differences between continuous and intermittent infusion of vancomycin for serious MRSA infections
  • Recognizing appropriate loading doses of vancomycin for serious MRSA infections
  • Identifying dosing considerations in obesity when using vancomycin for serious MRSA infections
Instructions
Answer All QuestionsYou must answer each question to move forward.
Get Instant FeedbackAfter you submit each answer, you'll receive an explanation.
Progress is Saved AutomaticallyYour progress is saved as you go, so you can stop and return to the quiz anytime.
Compare Your ResultsSee how your performance compares with your peers after each answer is submitted.
Earn PointsPoints are awarded for each correct answer.
Members Only FeaturesIf you're a member, you can track your progress and view the quizzes you've completed.
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.